US2009005861A1PendingUtilityA1

Stent coatings with engineered drug release rate

Assignee: HOSSAINY SYED F APriority: Jun 21, 2002Filed: Jun 9, 2008Published: Jan 1, 2009
Est. expiryJun 21, 2022(expired)· nominal 20-yr term from priority
A61L 31/16A61L 31/10A61L 2420/08
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Coatings and methods of forming coatings for implantable medical devices, such as stents, are described. The coatings are used for the sustained release of a therapeutic agent or drug.

Claims

exact text as granted — not AI-modified
1 . A stent having a coating, the coating comprising a first region including a thermoplastic polyacrylate material and a therapeutic substance and a second region free from any therapeutic substances disposed on the surface of the stent and beneath the first region, additionally including a third region disposed over the first region, the third region including a thermoplastic polyacrylate material and optionally a therapeutic substance. 
   
   
       2 . A stent having a coating, the coating comprising a first region including a thermoplastic polyacrylate material and a therapeutic substance and a second region free from any therapeutic substances disposed on the surface of the stent and beneath the first region, wherein the first region has a variable thickness along at least a segment of the length of the stent. 
   
   
       3 . A stent having a coating, the coating comprising a first region including a thermoplastic polyacrylate material and a therapeutic substance and a second region free from any therapeutic substances disposed on the surface of the stent and beneath the first region,
 wherein the concentration of the substance is greater in a first area of the first region than in a second area of the first region.   
   
   
       4 . A stent comprising a coating, wherein the coating comprises a first, second, and third layers disposed over one another wherein the second layer includes a thermoplastic polyacrylate material,
 wherein at least one of the layers includes a therapeutic substance,   wherein the first layer is disposed on the outer surface of the stent, and   wherein the third layer comprises a polymer selected from the group consisting of fluorinated polymers, poly(ethylene-co-vinyl alcohol), polydioxanone, poly(glycolic acid-co-trimethylene carbonate), polyphosphoester, polyphosphoester urethane, polycyanoacrylates, poly(trimethylene carbonate), poly(iminocarbonate), co-poly(ether-esters), polyalkylene oxalates, polyurethanes, silicones, polyisobutylene, ethylene-alphaolefin copolymers, vinyl halide polymers and copolymers, polyvinyl ethers, polyvinylidene chloride, polyacrylonitrile, polyvinyl ketones, polyvinyl aromatics, ethylene-methyl methacrylate copolymers, acrylonitrile-styrene copolymers, ABS resins, polyamides, alkyd resins, polyoxymethylenes, polyimides, polyethers, epoxy resins, polyurethanes, rayon, rayon-triacetate, fibrin, fibrinogen, cellulose, collagen, hyaluronic acid, cellulose acetate, cellulose butyrate, cellulose acetate butyrate, cellophane, cellulose nitrate, cellulose propionate, cellulose ethers, and carboxymethyl cellulose.   
   
   
       5 . The stent of  claim 4 , wherein the therapeutic substance is contained in the second layer and optionally the third layer but not the first layer. 
   
   
       6 . The stent of  claim 4 , wherein the first layer and the third layer include the therapeutic substance but not the second layer. 
   
   
       7 . The stent of  claim 6 , wherein the first layer is disposed on a primer layer, the primer layer being disposed on the surface of the stent. 
   
   
       8 . The stent of  claim 4 , wherein the first layer includes a polyacrylate material, and wherein at least one of the layers is free from any therapeutic substances. 
   
   
       9 . The stent of  claim 8 , wherein the first layer is disposed on the outer surface of the stent and is free from any therapeutic substances. 
   
   
       10 . A stent comprising a coating containing an active agent or a combination of active agents, the coating having a variable thickness along at least a portion of the length of the stent so as to provide a concentration gradient of the active agent or agents along from a thin region of the coating to the thick region of the coating. 
   
   
       11 . A method of coating a stent comprising forming a coating on the stent, the coating including a first region having a thermoplastic polyacrylate material and a therapeutic substance and a second region free from any therapeutic substances disposed on the surface of the stent beneath the first region,
 wherein the second region comprises a polymer selected from polydioxanone, poly(glycolic acid-co-trimethylene carbonate), polyphosphoester, polyphosphoester urethane, polycyanoacrylates, poly(trimethylene carbonate), poly(iminocarbonate), co-poly(ether-esters), polyalkylene oxalates, polyurethanes, silicones, polyisobutylene, ethylene-alphaolefin copolymers, vinyl halide polymers and copolymers, polyvinyl ethers, polyvinylidene chloride, polyacrylonitrile, polyvinyl ketones, polyvinyl aromatics, ethylene-methyl methacrylate copolymers, acrylonitrile-styrene copolymers, ABS resins, polyamides, alkyd resins, polyoxymethylenes, polyimides, polyethers, epoxy resins, polyurethanes, rayon, rayon-triacetate, fibrin, fibrinogen, cellulose, collagen, hyaluronic acid, cellulose acetate, cellulose butyrate, cellulose acetate butyrate, cellophane, cellulose nitrate, cellulose propionate, cellulose ethers, and carboxymethyl cellulose.   
   
   
       12 . A method of coating a stent, comprising forming at least three layers of coating on a stent,
 wherein the second layer includes a thermoplastic polyacrylate material,   wherein at least one of the layers includes a therapeutic substance,   wherein the first layer is disposed on the outer surface of the stent, and   wherein the third layer comprises a polymer selected from the group consisting of fluorinated polymers, poly(ethylene-co-vinyl alcohol), polydioxanone, poly(glycolic acid-co-trimethylene carbonate), polyphosphoester, polyphosphoester urethane, polycyanoacrylates, poly(trimethylene carbonate), poly(iminocarbonate), co-poly(ether-esters), polyalkylene oxalates, polyurethanes, silicones, polyisobutylene, ethylene-alphaolefin copolymers, vinyl halide polymers and copolymers, polyvinyl ethers, polyvinylidene chloride, polyacrylonitrile, polyvinyl ketones, polyvinyl aromatics, ethylene-methyl methacrylate copolymers, acrylonitrile-styrene copolymers, ABS resins, polyamides, alkyd resins, polyoxymethylenes, polyimides, polyethers, epoxy resins, polyurethanes, rayon, rayon-triacetate, fibrin, fibrinogen, cellulose, collagen, hyaluronic acid, cellulose acetate, cellulose butyrate, cellulose acetate butyrate, cellophane, cellulose nitrate, cellulose propionate, cellulose ethers, and carboxymethyl cellulose.   
   
   
       13 . A method of coating a stent comprising depositing a coating on the stent wherein the coating has a variable thickness along at least a segment of the length of the stent. 
   
   
       14 . A method of coating a stent, comprising,
 depositing a first layer on the stent, the first layer including a first therapeutic substance;   masking a region of the first layer; and   depositing a second layer on the first layer not covered by the masking layer, the second layer including a second therapeutic substance.

Join the waitlist — get patent alerts

Track US2009005861A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.